D. Garbuzenko

发表

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis

D. Garbuzenko, Dmitry V. Garbuzenko, 2022, Russian Journal of Gastroenterology, Hepatology, Coloproctology.

Non-alcoholic fatty liver disease as an independent factor of cardiometabolic risk of cardiovascular diseases

D. Garbuzenko, D. Belov, 2021, Experimental and Clinical Gastroenterology.

The role of transesophageal echocardiography in gastrointestinal bleeding

A. A. Semagin, A. Fokin, D. Garbuzenko, 2022, Kardiologiya i serdechno-sosudistaya khirurgiya.

Principles of diagnosis and treatment of alcohol-induced liver fibrosis

D. Garbuzenko, 2022, Meditsinskiy sovet = Medical Council.

Non-invasive diagnosis of liver fibrosis associated with nonalcoholic steatohepatitis

D. Garbuzenko, 2021, Dokazatel'naya gastroenterologiya.

[The role of antiviral therapy in the management of patients with liver cirrhosis associated with chronic HBV and HCV infection].

D. Garbuzenko, 2021, Voprosy virusologii.

Current strategies for targeted therapy of liver fibrosis

D. Garbuzenko, 2022, Bulletin of Siberian Medicine.

Gut microbiota modulation in acute decompensation of liver cirrhosis: theory and therapeutic potential

D. Garbuzenko, 2022, Dokazatel'naya gastroenterologiya.

[A rare case of gerniation and incarceration of the gallbladder].

D. V. Belov, D. Garbuzenko, S. S. Anufrieva, 2021, Khirurgiia.

Heyde’s syndrome as a rare cause of gastrointestinal bleeding in aortic stenosis patients

D. V. Belov, D. Garbuzenko, O. P. Lukin, 2021, Cardiovascular Therapy and Prevention.

Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis

D. Garbuzenko, 2022, The Russian Archives of Internal Medicine.

Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis

D. Garbuzenko, 2018, Russian Journal of Gastroenterology, Hepatology, Coloproctology.